Physician profile
Brence Brooks
NPI 1396340410
$2,343.46
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $934 · 2022: $1,379 · 2024: $30.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $368.15 | 2021-2024 | Spravato |
| Abbvie INC. | $334.70 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $271.05 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $209.71 | 2021-2022 | |
| Bausch Health US, LLC | $157.48 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $154.87 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $151.61 | 2021-2024 | Rexulti, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $134.42 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $111.64 | 2021-2022 | |
| Indivior INC. | $71.50 | 2021-2022 | |
| Corium, LLC | $61.50 | 2022 | |
| Neos Therapeutics, Lp | $56.00 | 2022 | |
| Alkermes, INC. | $53.82 | 2022 | |
| Lundbeck LLC | $50.52 | 2021 | |
| Ironshore Pharmaceuticals INC. | $44.21 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $38.53 | 2022 | |
| Neurocrine Biosciences, INC. | $27.70 | 2021-2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $17.63 | 2021 | |
| Jazz Pharmaceuticals INC. | $15.22 | 2022 | |
| Almatica Pharma LLC | $13.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brence Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.